Related Experiment Video

Updated: May 3, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

14.5K

The apolipoprotein gene and recovery from brain injury among extremely preterm infants

James A Blackman1, Heather Gordish-Dressman, Yondge Bao

  • 1Department of Pediatrics, University of Virginia, Charlottesville, Va., USA.

Neonatology
|February 8, 2014
PubMed

Insights

The apolipoprotein E (APOE) gene, involved in neuron repair, was studied in extremely preterm infants. Researchers found no direct link between APOE alleles and developmental outcomes or brain injury in these vulnerable infants.

Area of Science:

  • Neuroscience
  • Genetics
  • Neonatalogy

Background:

  • Extremely preterm infants face high risks of brain injury, potentially leading to motor, cognitive, or behavioral impairments.
  • Genetic factors, such as the apolipoprotein E (APOE) gene, may influence brain injury response and recovery.
  • The APOE gene provides instructions for making a protein crucial for neuronal maintenance and repair in the brain.

Purpose of the Study:

  • To investigate the association between APOE gene alleles and developmental outcomes in extremely preterm infants.
  • To determine if specific APOE alleles correlate with improved neurological recovery after early brain injury.

Main Methods:

  • Genotyping for APOE alleles was performed on 87 extremely preterm infants (birth weight < 1,000 g).
  • Developmental assessments using the Bayley III Scales were conducted on 71 infants at 12-15 months corrected age.
  • Brain MRI scans were acquired for 52 infants at term equivalent to evaluate brain structure.

Main Results:

  • No statistically significant association was observed between the three common APOE alleles and the developmental outcomes measured by the Bayley III Scales.
  • Analysis of brain MRI findings revealed no significant relationship between APOE alleles and indicators of white or gray matter injury.
  • The presence of specific APOE alleles did not predict better or worse neurological status in this cohort.

Conclusions:

  • The APOE gene does not appear to directly influence the developmental consequences of white or gray matter injury in extremely preterm infants.
  • Findings suggest that APOE's role in neuronal repair may not be a primary determinant of long-term neurodevelopmental outcomes in this high-risk population.
  • Further research may be needed to explore other genetic or environmental factors impacting brain injury recovery in preterm neonates.
Abstract

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

10.5K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.4K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
25
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35